International Summit on Health, Biotech and Clinical Evidence

Conference scope

A health sciences meeting for clinical evidence, biotechnology, public health, diagnostics, trials, and translational medicine.

Audience

Researchers, editors, institutional leaders, students, librarians, policy teams, industry research groups, and conference partners.

Program formats

Keynotes, invited talks, oral sessions, poster sessions, panel discussions, workshops, and proceedings-ready abstract collections.

Transparency route

Event information, review route, committee responsibility, sponsorship, proceedings label, and correction pathway are stated before publication.

Proceedings note

Conference acceptance is separate from journal article acceptance. Expanded papers must pass the relevant journal review process.

Abstract review and proceedings

Conference abstracts are checked for relevance, originality, clarity, ethical declarations, and program fit. Proceedings are labeled separately from journal articles and do not imply journal acceptance.

1 Abstract submission and topic classification 2 Scientific committee or reviewer assessment 3 Program decision, author notification, and revision if required 4 Proceedings labeling, metadata preparation, and publication record updates

Participant and publication standards

Abstracts must not include fabricated results, misleading claims, or undisclosed conflicts.
Human or animal research must include approval and consent information where applicable.
Sponsored sessions, special sessions, and proceedings collections must be identified clearly.
Corrections, withdrawals, complaints, and retractions remain available for published proceedings content.